Rifaximin Reduces Risk of Traveler's DiarrheaRifaximin Reduces Risk of Traveler's Diarrhea

Prophylaxis with oral rifaximin halved the risk of diarrhea during travel to south and southeast Asia in a phase III trial. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news